BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 34212373)

  • 1. Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.
    Sánchez R; Dorado S; Ruíz-Heredia Y; Martín-Muñoz A; Rosa-Rosa JM; Ribera J; García O; Jimenez-Ubieto A; Carreño-Tarragona G; Linares M; Rufián L; Juárez A; Carrillo J; Espino MJ; Cáceres M; Expósito S; Cuevas B; Vanegas R; Casado LF; Torrent A; Zamora L; Mercadal S; Coll R; Cervera M; Morgades M; Hernández-Rivas JÁ; Bravo P; Serí C; Anguita E; Barragán E; Sargas C; Ferrer-Marín F; Sánchez-Calero J; Sevilla J; Ruíz E; Villalón L; Del Mar Herráez M; Riaza R; Magro E; Steegman JL; Wang C; de Toledo P; García-Gutiérrez V; Ayala R; Ribera JM; Barrio S; Martínez-López J
    Sci Rep; 2022 Jul; 12(1):13057. PubMed ID: 35906470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and prognostic influence of ASXL1 mutations and its potential association with BCR-ABL1 transcript type and smoke in chronic myeloid leukemia patients.
    Rafiq Mohammed A; Assad D; Rostami G; Hamid M
    Gene; 2023 Nov; 886():147776. PubMed ID: 37689224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.
    Piazza R; Valletta S; Winkelmann N; Redaelli S; Spinelli R; Pirola A; Antolini L; Mologni L; Donadoni C; Papaemmanuil E; Schnittger S; Kim DW; Boultwood J; Rossi F; Gaipa G; De Martini GP; di Celle PF; Jang HG; Fantin V; Bignell GR; Magistroni V; Haferlach T; Pogliani EM; Campbell PJ; Chase AJ; Tapper WJ; Cross NC; Gambacorti-Passerini C
    Nat Genet; 2013 Jan; 45(1):18-24. PubMed ID: 23222956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Hochhaus A; Saussele S; Rosti G; Mahon FX; Janssen JJWM; Hjorth-Hansen H; Richter J; Buske C;
    Ann Oncol; 2017 Jul; 28(suppl_4):iv41-iv51. PubMed ID: 28881915
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue-Predisposition to Cancer Driver Mutations.
    Peters L; Venkatachalam A; Ben-Neriah Y
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic myeloid leukaemia following repeated exposure to chest radiography and computed tomography in a patient with pneumothorax: A case report and literature review.
    Ju FH; Gong XB; Jiang LB; Hong HH; Yang JC; Xu TZ; Chen YU; Wang Z
    Oncol Lett; 2016 Apr; 11(4):2398-2402. PubMed ID: 27073486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum to "Histone demethylase PHF8 facilitates the development of chronic myeloid leukaemia by directly targeting BCR::ABL1".
    Br J Haematol; 2024 May; 204(5):2134-2135. PubMed ID: 38567568
    [No Abstract]   [Full Text] [Related]  

  • 8. Mixed phenotype acute leukaemia with monosomy 7 and BCR-ABL1 translocation following antimetabolite therapy for intrahepatic cholangiocarcinoma.
    Ray D; Naseem S; Sreedharanunni S; Sharma N
    J Hematop; 2022 Mar; 15(1):41-43. PubMed ID: 38358603
    [No Abstract]   [Full Text] [Related]  

  • 9. [Expert consensus on the pathological diagnosis of BCR::ABL1-negative myeloproliferative neoplasms in China (2023 version)].
    ; ;
    Zhonghua Bing Li Xue Za Zhi; 2023 Sep; 52(9):891-901. PubMed ID: 37670617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology.
    Combaluzier S; Quessada J; Abbou N; Arcani R; Tichadou A; Gabert J; Costello R; Loosveld M; Venton G; Berda-Haddad Y
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Treatment of a Patient with Chronic Myelogenous Leukemia with Concurrent Janus Kinase 2 (JAK2) R795S Mutation and Breakpoint Cluster Region-ABL1 (BCR-ABL1) Fusion: A Case Report and Literature Review.
    Yue Y; Wei W; Guo Y; Wang F; Dong W; Liu Y; Lin Y; Cao Y; Gu W
    Am J Case Rep; 2020 Oct; 21():e925151. PubMed ID: 33021971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations.
    Turakhia SK; Murugesan G; Cotta CV; Theil KS
    J Clin Pathol; 2016 Aug; 69(8):713-9. PubMed ID: 26754830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor.
    Fava C; Rege-Cambrin G; Dogliotti I; Gottardi E; Berchialla P; Di Gioacchino B; Crasto F; Lorenzatti R; Volpengo A; Daraio F; Fantino C; Saglio G
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S96-S100. PubMed ID: 27131622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up.
    Romzova M; Smitalova D; Hynst J; Tom N; Loja T; Herudkova Z; Jurcek T; Stejskal L; Zackova D; Mayer J; Racil Z; Culen M
    Br J Haematol; 2021 Aug; 194(3):604-612. PubMed ID: 34212373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study.
    Kizilors A; Crisà E; Lea N; Passera R; Mian S; Anwar J; Best S; Nicolini FE; Ireland R; Aldouri M; Pocock C; Corbett T; Gale R; Bart-Smith E; Weston-Smith S; Wykes C; Kulasekararaj A; Jackson S; Harrington P; McLornan D; Raj K; Pagliuca A; Mufti GJ; de Lavallade H
    Lancet Haematol; 2019 May; 6(5):e276-e284. PubMed ID: 31036317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants.
    Soverini S; De Benedittis C; Castagnetti F; Gugliotta G; Mancini M; Bavaro L; Machova Polakova K; Linhartova J; Iurlo A; Russo D; Pane F; Saglio G; Rosti G; Cavo M; Baccarani M; Martinelli G
    BMC Cancer; 2016 Aug; 16():572. PubMed ID: 27485109
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.